Moreover, the high abundance and constant secretion of EVs (that harbor PD-L1) in CLL may simply outcompete the blocking activity of anti-PD-1/PD-L1 antibodies. The gene discussed is CD274; the disease is B-cell chronic lymphocytic leukemia.